Mechanisms of Hypothalamic Release of Srif and Grf

Aguila, M Cecilia

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Neurological Disorders and Stroke (NINDS)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 5R29NS026821-05
• Application #: 2266134
• Study Section: Neurological Sciences Subcommittee 1 (NLS)
• Program Officer: Kitt, Cheryl A
• Project Start: 1991-05-01
• Project End: 1997-04-30
• Budget Start: 1995-05-01
• Budget End: 1997-04-30
• Support Year: 5
• Fiscal Year: 1995

Institution

• Name: University of Texas Sw Medical Center Dallas
• Department: Physiology
• Type: Schools of Medicine
• City: Dallas
• State: TX
• Country: United States
• Zip Code: 75390

Publications

Aguila, M C (1994) Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase. Proc Natl Acad Sci U S A 91:782-6

Karanth, S; Aguila, M C; McCann, S M (1993) The influence of interleukin-2 on the release of somatostatin and growth hormone-releasing hormone by mediobasal hypothalamus. Neuroendocrinology 58:185-90

Aguila, M C; McCann, S M (1993) Growth hormone increases somatostatin release and messenger ribonucleic acid levels in the rat hypothalamus. Brain Res 623:89-94

Aguila, M C; Boggaram, V; McCann, S M (1993) Insulin-like growth factor I modulates hypothalamic somatostatin through a growth hormone releasing factor increased somatostatin release and messenger ribonucleic acid levels. Brain Res 625:213-8

Aguila, M C; Dees, W L; Haensly, W E et al. (1991) Evidence that somatostatin is localized and synthesized in lymphoid organs. Proc Natl Acad Sci U S A 88:11485-9